| 1 |
Fehr AR, Perlman S．Coronaviruses：an overview of their replication and pathogenesis[J]．Methods Mol Biol，2015，(1282):1-23.
|
| 2 |
陈云欢，伍严安．两种新型人冠状病毒HCoV-NL63和HCoV-HKU1的研究进展[J]．医学综述，2010，16(17):2596-2598.
|
| 3 |
Guan Y, Zheng BJ, He YQ，et al.Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China[J]．Science，2003，302(5643):276-278.
|
| 4 |
刘培林，史蕾，顾大勇，等．人冠状病毒HCoV-HKU1研究进展[J]．中国公共卫生，2017，33(8):1264-1266.
|
| 5 |
Chafekar A, Fielding BC.MERS-CoV：Understanding the latest human coronavirus threat[J]．Viruses，2018，10(2):93.
|
| 6 |
Lu R, Zhao X, Li J，et al.Genomic characterisation and epidemiology of 2019 novel coronavirus：implications for virus origins and receptor binding[J]．Lancet，2020，395(10224):565-574.
|
| 7 |
Zhou P, Yang XL, Wang XG，et al.A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]．Nature, 2020，579(7798):270-273.
|
| 8 |
李鹤，谭晓川，姜栋，等．冠状病毒及其治疗药物研究进展[J]．中国药学杂志，2020，55(4):284-292.
|
| 9 |
Heurich A, Hofmann-Winkler H, Gierer S，et al.TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein[J]．J Virol，2014，88(2):1293-1307.
|
| 10 |
Hamming I, Timens W, Bulthuis ML，et al.Tissue distribution of ACE2 protein，the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis[J]．J Pathol，2004，203(2):631-637.
|
| 11 |
Yan RH, Zhang YY, Guo YY，et al.Structural basis for the recognition of the 2019-nCoV by human ACE2[J/OL]．bioRxiv，2020 [2020-02-20]．
URL
|
| 12 |
搜狐．新冠病毒侵染人体那一刻发生了什么？西湖大学深入破解 [EB/OL]．(2020-02-23)[2020-03-06]．
URL
|
| 13 |
Wrapp D, Wang N, Corbett KS，et al.Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation[J]．Science，2020，367(6483):1260-1263.
|
| 14 |
国家卫生健康委办公厅，国家中医药管理局办公室．关于印发新型冠状病毒肺炎诊疗方案(试行第七版)的通知[EB/OL]．(2020-03-04)[2020-03-06]．
URL
|
| 15 |
刘千勇，王晓良．新型冠状病毒(2019-nCoV)的靶向药物研究策略[J]．药学导报，2020，55(2):181-188.
|
| 16 |
陈祝君，边原，杨勇，等．新型冠状病毒感染性肺炎中成药的合理使用[J/OL]．医药导报，2020[2020-02-11].
URL
|
| 17 |
中国新闻网．李兰娟团队：阿比朵尔、达芦那韦能有效抑制冠状病毒[EB/OL]．(2020-02-04)[2020-03-06]．
URL
|
| 18 |
人民日报、中国网．国务院联防联控机制新闻发布会：磷酸氯喹治疗新冠肺炎具有一定疗效[EB/OL]．(2020-02-17)．[2020-03-06]．
URL
|
| 19 |
优酷．抗体才是治疗新冠状病毒最好药物，武汉已从治愈患者身体成功提出[EB/OL]．(2020-02-15)[2020-03-06]．
URL
|
| 20 |
熊堉，蒋敏，边原，等．探索利巴韦林治疗新型冠状病毒肺炎的有效性和安全性：基于既往冠状病毒治疗的总结[J/OL]．医学导报，2020[2020-02-13]．
URL
|
| 21 |
Knowles SR, Phillips EJ, Dresser L，et al.Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada[J]．Clin Infect Dis，2003，37(8):1139-1142.
|
| 22 |
Sheahan TP, Sims AC, Leist SR，et al.Comparative therapeutic efficacy of remdesivir and combination lopinavir，ritonavir，and interferon beta against MERS-CoV[J]．Nat Commun，2020，11(1):222.
|
| 23 |
Gassen NC, Niemeyer D, Muth D，et al.SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection[J]．Nat Commun，2019，10(1):5770.
|
| 24 |
Jones ST, Cagno V, Janeček M，et al.Modified cyclodextrins as broad-spectrum antivirals[J]．Sci Adv，2020，6(5):eaax9318.
|
| 25 |
中国军网综合．大好消息！目前新冠肺炎相关研究已获诸多成果[EB/OL]．(2020-03-04)．[2020-03-06]
URL
|
| 26 |
Tang XL, Wu CC, Li X，et al.On the origin and continuing evolution of SARS-CoV-2[J]．NSR，2020[2020-03-03]．
URL
|